Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment

US6930207B2 · kind B2 · utility

Assignee

• Solvay Pharmaceuticals, GmbH · US

Inventors

• Jochen Antel · Annaberg-Buchholz, DE
• Harald Waldeck · Hannover, DE
• Andreas Potthoff · Goldkronach, DE
• Sabine Irmer · Hannover, DE
• Peter-Colin Gregory · Hannover, DE

Key dates

• Filing date: Jan 16, 2004
• Grant date: Aug 16, 2005
• Expiry date: Jan 16, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel and known trifluoroacetyl-substituted phenyl, phenol and benzoyl compounds for the treatment and/or inhibition of obesity and of concomitant and/or secondary diseases involved therewith, in particular metabolic syndrome and cardiovascular diseases. Novel trifluoroacetyl-substituted phenyl, phenol and benzoyl compounds, pharmaceutical preparations containing them and processes for the preparation of these compounds. Also compounds acting as inhibitors of lipase, in particular pancreatic lipase.